Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
The Cancer Journal From Scientific American|April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapyG Gasparini, M Toi, R Miceli, et al.
Oncology|October 17, 2002
Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancerS Palmeri, V Leonardi, M Tamburo De Bella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancerS Cascinu, R R Silva, R Labianca, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerD Amadori, C Milandri, G Comella, et al.
Clinical Drug Investigation|October 23, 2012
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritisL Gallelli, O Galasso, A Urzino, et al.
Nephron|June 26, 2001
Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutationsA Sessa, G Battini, M Meroni, et al.
The American Journal of Pathology|November 14, 1997
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesisF Pezzella, U Pastorino, E Tagliabue, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Structure guided mutagenesis of Henipavirus Receptor Binding Proteins reveals molecular determinants of receptor usage and antibody binding epitopesK Y Oguntuyo, G D Haas, K D Azarm, et al.
British Journal of Cancer|August 23, 2000
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin InvestigatorsC Gridelli, L Frontini, F Perrone, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 14, 2011
Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2M A Ionescu, A Baroni, L Brambilla, et al.
Pageof 39